Vectors combining the heat shock proteins (HSPs) promoter with the catalytic subunit A of the diphtheria toxin (DTA) or its variants, cross-reacting material (CRM) 176 and 197, were engineered to investigate the effect of bacterial toxins on pancreatic cancer (PC) cells. Three heat-inducible enhanced green fluorescent protein (eGFP)-expression vectors were obtained: V1 (91% homology to HSPA6), V2 (five heat shock elements upstream the minimal HSPA6 promoter) and V3 (V1 and V2 combined). The highest eGFP transcription and translation levels were found in V3 transfected PC cells. The V3 promoter was used to control DTA, CRM176 and CRM197 expression, treatment response being investigated in four PC cell lines. DTAwt or CRM176 transfected cell growth was completely arrested after heat shock. CRM197 toxin presumed to be inactive, caused mild distress at 37 1C and induced a 25-50% reduction in cell growth after heat shock. Preliminary in vivo findings showed that heat treatment arrests tumor growth in DTA197 stably transfected PSN1 cells. In conclusion, the efficient HSP promoter identified in this study may be extremely useful in controlling the transcription of toxins such as CRM197, which have lethal dose-related effects, and may thus be a promising tool in PC gene therapy in vivo.
Introduction
Despite undergoing surgery and/or chemotherapy, 480% of pancreatic cancer (PC) patients survive for no longer than 5 years after diagnosis. 1 This dismal prognosis depends on several factors, including the resistance of PC cells to almost all available antineoplastic drugs. 2 Efforts have, therefore, been made to develop new therapeutic approaches involving gene and immunotoxin therapy. [3] [4] [5] [6] However, the efficacy of gene therapy, designed to correct inherited or acquired genetic defects and/or confer new genetic and phenotypic characteristics to cells, 3, 4, 7 is limited in the treatment of PC. 3, 4, [8] [9] [10] [11] [12] [13] [14] Immunotoxins, bacteria or plant-derived protein toxins vehicled by molecules bind target antigens or receptors to the cell surface, 5, 6, [15] [16] [17] the most widely used products being diphtheria toxin (DT) and pseudomonas exotoxin, which arrest cytosolic protein synthesis by modifying the elongation factor 2.
5,15-17 Among DT-derived molecules, the cross-reacting material (CRM) variants 176 and 197 have the same immunological properties as DT, but incur a different toxicity because of glycine 128 replacement with aspartic acid (CRM176) or glycine 52 replacement with glutamic acid (CRM197), respectively. 18, 19 Recombinant cytotoxic fusion proteins carrying the enzymatically active portion of the DT and receptor-binding domains of IL-2 or of IL-3 have been successfully used in the treatment of T-cell lymphoma and acute myeloid leukemia in human beings. 20, 21 An immunotoxin construct consisting of the vehicle, epidermal growth factor (EGF) and the toxin, DT, has been used for PC immunotoxin therapy in vitro, and in animal models, [22] [23] [24] as EGF receptor (EGFR) is known to be over-expressed in this tumor type. 25 However, EGFR expression by tissue, other than pancreatic tumor tissue, may cause nonspecific toxicity with side effects, such as fever, pain, hypoalbuminemia, increased transaminase levels and vascular leakage. [26] [27] [28] New models should, therefore, be developed to ensure that the action of bacterial toxins is contained within PC cells.
This study was conducted to investigate the efficacy of gene therapy with the heat shock proteins (HSPs) promoter combined with DT-derived molecules in the treatment of PC. HSPs, highly conserved cytoprotective proteins found in all animal species, have a fundamental function in protein folding, transport, translocation, degradation and assembly; 29 their transcription is triggered when cytoplasmic heat shock factor monomers have been trimerized, translocated into the nucleus and recognized by specific promoter motifs, the so-called heat shock elements (HSEs). 30 Although HSP expression was originally observed in cells after acute stress, 31 several members of this family are constitutively expressed; 30, 32, 33 however, HSPs with inducible rather than constitutive expression seem more suitable for gene therapy applications, as inducible expression can be manipulated.
HSP70 is particularly suitable for PC gene therapy, as it is (1) expressed by PC cells; [34] [35] [36] (2) heat activated and modulated, with little or no basal expression; 33 (3) highly efficient-after heat shock, the expression levels of reporter genes are comparable to those of constitutive promoters; 37 (4) suitable for spatial control-external beam radiation by focused ultrasounds can allow accurate control of gene expression. 38 Hsp70B', which belongs to the HSP70 family and is encoded by the HSPA6 gene located on chromosome 1, is reported to be exclusively induced by cellular stress. 39 In this study, the HSPA6 promoter, an artificial sequence encompassing five tandem HSEs and a combination of both, was engineered into mammalian-expression vectors to identify an efficient heat-inducible promoter for controlling the expression of DT and its variants, CRM176 and CRM197, to treat PC in vitro and in vivo.
Materials and methods

Enhanced green fluorescent protein vectors
The cloning steps used to obtain the heat-inducible vectors are shown in Supplementary Figure 1 . Vectors 1, 2 and 3 (V1, V2 and V3) were enhanced green fluorescent protein (eGFP) mammalian-expression vectors, each with different heat-inducible promoter regions. The V1 promoter contains a sequence that is 91% homologous with HSPA6; 40 the V2 promoter is an artificial construct encompassing five HSEs (Supplementary Figure 2) ; the V3 promoter consists of a V2 promoter inserted downstream in the V1 promoter. Details on V1, V2 and V3 are reported in the Supplementary Material.
DTA vectors
Three further vectors were engineered; all shared the V3 promoter, but each had a different toxic moiety, wich was the coding sequence of the A fragment of DT (DTAwt), CRM176 (DTA176) and CRM197 (DTA197) DTA variants, respectively. Details on these vectors are reported in the Supplementary Material.
Transient and stable transfection PC cell lines. They included BxPC3 (kindly donated by A Galli, Florence, Italy), MIAPaCa2 (American Type Culture Collection, Manassas, VA), PANC1 and PSN1 (kindly donated by A Scarpa, Verona, Italy). These four PC cell lines, which in vitro partly represent the heterogeneity of this tumor type, are all primary lines with different oncogenes and tumor suppressor gene mutations. 13 Before chemical transfection, the cells were maintained in continuous culture in conditions described elsewhere. 12 Transiently transfected cell lines. A measure of 4 mg plasmids were incubated with 10 ml Lipofectamine 2000 (Invitrogen, San Giuliano Milanese, Italy) in 500 ml serum and antibiotic-free DMEM (Invitrogen) for 20 min at 25 1C. The reagent was then directly added to each cell culture well (200 000 cells) in a 6-well plate format. After 6 h, media were replaced with fresh serum supplemented media and the cells maintained at 37 1C for the subsequent 24 h before starting heat shock experiments.
Stably transfected cell lines. To obtain stable transformed cells lines, the cells were treated with 1 mg ml -1 G418 (Invitrogen) for 15 days after transfection. For in vivo experiments PSN1 cells were transduced by a luciferase-coding lentiviral vector, as described earlier. 41 Heat shock experiments Stably V1 transfected cell lines were used to define the optimal temperature and exposure time interval for heat shock. Control cells were maintained at 37 1C, whereas experimental cells were heat shocked by immersion in a high precision water bath (GFL, Burgwedel, Germany). In the first set of experiments, conducted to identify the optimal temperature, experimental cultures were subjected to heat shock for 2 h at 38, 39, 40, 41, 42, 42.5, 43 and 44 1C, and returned to 37 1C for the subsequent 24 h. In the second set of experiments, conducted to identify the optimal exposure time interval, experimental cultures were subjected to heat shock at 42.5 1C for 0.5, 1, 1.5, 2, 2.5 and 3 h, and returned to 37 1C for the subsequent 24 h. Cells were then harvested with trypsin EDTA (Invitrogen) and re-suspended in phosphate buffer saline before measuring eGFP fluorescence by flow cytometry (FACS). After defining the optimal temperature and exposure time interval, transient V1, V2 and V3 transfected cell lines were used to compare the transcription and translation levels of the reporter gene, eGFP. Control cells were maintained at 37 1C, whereas experimental cells were heat shocked at 42.5 1C for 1.5 h. For quantitative mRNA analysis, experimental cells (2 Â 10 6 ) were harvested 0.5, 2.5, 4.5, 6.5 and 24 h after thermal shock. The findings made were compared with those obtained in the same number of control cells. Twenty-four hours after heat shock, eGFP-expression levels in control and experimental cells were evaluated using both FACS and western blot. In vivo experiments. Seventeen female nude mice (age, 6 weeks) were purchased from Charles River (Lecco, Italy) and housed in pathogen-free conditions. The experimental procedure was conducted in conformity with institutional guidelines, in compliance with national and international laws and policies (EEC Council Directive 86/609, OJ L 358, 12 December 1987). The first series, consisting of six mice, was used to optimize the in vivo heat shock protocol. Each mouse was subcutaneously (s.c.) inoculated in both flanks with three million V3 transfected PSN1 cells, mixed in a 1:2 ratio with liquid Matrigel (Sacco, Como, Italy) to a final volume of 300 ml. When tumor volumes were 200-300 mm 3 , heat treatment initiated, being given using an 'in house' assembled instrument made of an aluminum block with a surface area of 1.5 cm 2 to be directly applied to the surface of the tumor. The temperature of the block, which was heated by a resistor, was electronically controlled by a microprocessor with a digital temperature sensor, variations being limited to ±1 1C. Before any in vivo application, the heating device was validated by conducting temperature controls using a reference thermometer. Two of the six V3 PSN1 inoculated mice, used as controls, were not heat treated. The remaining mice underwent one (two mice) or two (two mice, 72-h intervals between first and second treatment) heat treatments (42 1C for 15 min); a damp gauze strip was placed between the aluminum block and the cutaneous surface to prevent skin lesions. Four hours after the end of the heat shock protocol, mice were killed by cervical dislocation and the tumors were harvested by dissection, immediately frozen in liquid nitrogen, and then homogenized in an extraction buffer, used to measure the transfectant-expression levels (real-time PCR, described in Supplementary Material). A second series of 11 mice was used to assess the in vivo efficacy of the V3 DTA197 variant. Three million injection V3 DTA197 transfected PSN1 cells (seven mice) or PSN1 non-transfected cells (four mice), both transduced with a lentiviral vector encoding a firefly luciferase gene to obtain a luciferase þ cell population, were s.c. inoculated in both flanks. Two PSN1 and two PSN1-DTA197 inoculated mice (controls) received no treatment. One of the two tumor masses (tumor volume 200-300 mm 3 ) excised from two PSN1 and five PSN1-DTA197 inoculated mice were heated twice (72-h interval), as described above. Four hours after the end of treatment, the tumor masses from one control and two PSN1-DTA197 heat-treated mice were removed for measurement of transfectant-expression levels (DTA197 real-time PCR, details provided in Supplementary Material). The remaining PSN1 and PSN1-DTA197 untreated (2 and 1, respectively) and heat-treated (2 and 3, respectively) mice underwent a 9-day follow-up. Starting from the day of inoculation, the animals were inspected twice weekly and tumors measured using a caliper; the tumor volume was measured based on the formula, length Â width 2 Â 0.5.
Optical imaging. In vivo bioluminescence imaging was performed with a highly sensitive, cooled CCD camera mounted on a light-tight specimen box (IVIS Imaging System, Xenogen Corporation, Alemeda, CA). Ten minutes before imaging, animals were anesthetized and 150 mg kg -1 of D-luciferin (Biosynth AG, Staad, Switzerland) in Dulbecco's phosphate buffer saline was injected intraperitoneally. The signal intensity was quantified as the sum of all detected photon counts (total flux; photons per second) within a region of interest prescribed around the tumor sites using LivingImage software (Xenogen).
Statistical analysis of data
The statistical analysis of data was made using the Fisher's exact test, analysis of variance (one-way ANOVA), Bonferroni's test for pairwise comparisons and repeated measures analysis of variance (SPSS statistical software, version 9.0, Chicago, IL).
Results
Hsp70B' in PC cell lines
We first verified whether PC cell lines encode Hsp70B' and whether its expression is heat inducible. Cell extracts, collected 24 h after heat shock, were electrophoresed and blotted to identify the Hsp70B' protein, which was present in experimental cells, but absent in control cells (Supplementary Figure 3 ).
Optimal heat shock experimental conditions
To define the optimal heat shock experimental conditions, we used V1 stably transfected PC cell lines. With the exposure time interval set at 2 h, the heat shock temperature was increased stepwise from 37 1C (control cells) to 44 1C. eGFP expression was evaluated by FACS 24 h later (Figure 1a) . A maximal 4 (PANC1)-to 11 (PSN1)-fold increase in eGFP expression was found after exposure to the 42-43 1C range, no induction being observed at temperatures of o39 1C. For all cell lines, maximal transgene expression was obtained after exposure to 42.5 1C (Figure 1b) ; this temperature was, therefore, chosen for the subsequent experiments conducted to define the optimal heat shock exposure time interval.
The experimental cells were maintained at 42.5 1C for 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 h, whereas control cells were kept at 37 1C. eGFP fluorescence intensity peaked equally when heat shock was prolonged for a minimum of 1.5 to a maximum of 2.5 h. As the shorter exposure time required to guarantee V1 maximal transcription and translation was to be chosen, cell exposure at 42.5 1C for 1.5 h was identified to obtain optimal heat shock. Findings at western blot confirmed that under this experimental condition, eGFP protein expression occurred in all V1 stably transfected cell lines (MIAPaCa2; Figure 1 , bottom).
Comparison between V1, V2 and V3 expression eGFP fluorescence intensity was measured by FACS in V1, V2 and V3 transiently transfected control and experimental cells 24 h after heat shock. Table 1 reports mean values ± standard errors and the findings made at statistical analysis (repeated measures analysis of variance) for eGFP fluorescence intensity obtained in separate series of at least three experiments. After heat shock, V2 transfected cells expressed eGFP levels that were comparable (BxPC3) or higher (MIAPaCa2, PANC1, PSN1) than those in V1, although statistical significance was attained only for PANC1 cells. The V2 promoter, an artificial construct designed by us, was thus found to be as efficient as, or even more efficient than, the fragment Bam HI/Hind III of the plasmid 173OR, which shares an homology of about 91% with the HSPA6 promoter. However, the highest levels of expression after heat shock were reached in all V3 transfected PC cell lines. eGFP mRNA levels were quantified by quantitative-realtime PCR to verify whether the enhanced cell fluorescence effectively encompassed gene transcription in all stably transfected cell lines. For both experimental (42.5 1C for 1.5 h) and control cells (37 1C), three measurements were made 0.5, 2.5, 4.5, 6.5 and 24 h after heat shock. In experimental cells, eGFP mRNA levels rapidly increased 0.5 h after heat shock, levels remaining high from 2.5 to 6.5 h after the end of heat shock, but returning to baseline at 24 h. The statistical analysis of data was made considering the eGFP mRNA-fold increase with respect to its own control, measured in samples collected at 2.5, 4.5 and 6.5 h. As shown in Figure 2 , eGFP mRNA levels were significantly higher in V3 than in V1 and V2 MIAPaCa2 (one-way ANOVA: F ¼ 47.8, Po0.001) or PANC1 (F ¼ 16.7, Po0.01) transfected cell lines. V3 transfected BxPC3 line had significantly higher eGFP mRNA levels than V2 line (F ¼ 5.5, Po0.05), whereas V3 transfected PSN1 cell line had significantly higher eGFP mRNA levels than V1 (F ¼ 5.6, Po0.05) transfected cell line. Overall, V1 and V2 vectors triggered an increase in mRNA after heat shock, re-confirming that the artificial sequence designed by us induces gene transcription as efficiently as the Bam HI/Hind III fragment of the plasmid 173OR. V3 enhanced gene transcription to a greater extent than V1 or V2, the mRNA levels increase ranging from 20-to 30-fold. This finding was analogous to that made for the Hsp70B' protein. The V3 promoter was, therefore, selected for controlling DTAwt and DTA variant expression.
DTAwt, DTA176 and DTA197 toxicity Of the three V3-derived vectors engineered by us, one coded DTAwt and the other two coded the DTA variants, DTA gene therapy P Fogar et al CRM176 and CRM197. To ascertain whether DTA and DTA variants-coding vectors exert basal cellular toxicity, cell viability was assessed 1, 2, 3, 4 and 6 days after transient transfection; the cells, which were not heat shocked, were maintained at 37 1C. The findings made ( Figure 3) were compared with those obtained in nontransfected cells. Vectors encoding DTAwt and DTA176 significantly reduced, but did not completely inhibit, the growth of all cell lines studied. The safer construct for all cells was that coding DTA197: MIAPaCa2 and PANC1 completely tolerated the DTA197 vector, and BxPC3 and PSN1 growth was only slightly delayed. Table 2 reports the findings made for cellular growth in DTAwt, DTA176 and DTA197 transiently transfected or non-transfected cell lines after heat shock. DTAwt and DTA176 transfected MIAPaCa2, PANC1 and PSN1 cell growth was completely arrested when heat shock was applied, whereas DTAwt and DTA176 transfected BxPC3 cell growth was only slightly delayed. DTA197 transfected cells presented a different pattern: the heat-induced expression of the transfectant caused a mild inhibition of BxPC3, MIAPaCa2 and PANC1, whereas it almost completely inhibited PSN1 cell growth. The behavior of DTA197 transfected cells after heat shock (42.5 1C for 1.5 h) and at 37 1C is shown in Figure 4 .
The long-term growth in DTA197 stably transfected PSN1 cells was significantly reduced 14 (Po0.0001), 21 (Po0.0001) and 28 days (Po0.0001) after heat shock: on days 21 and 28, 0/48 and 1/48 positive wells were present in treated plates vs 23/48 and 16/48 positive results in the control plates.
In vivo experiments
To investigate V3-DTA197 vector toxicity in vivo, PSN1 cells were selected and s.c. inoculated in nude mice. A device allowing the heat treatment of very small areas and the optimal experimental conditions ascertained for achieving significant transgene expression by quantifying eGFP mRNA of tumors from V3 transfected PSN1 cells were developed. eGFP mRNA-fold increases with respect to the levels of untreated tumor masses were 2.34 and 5.59 for the two tumors heated once, and 9.32 and 8.89 for the two tumors heated twice. The latter protocol was, therefore, chosen for toxicity experiments, which were made using PSN1-DTA197. Figure 5a shows tumor mass growth in control and experimental mice, measured by a caliper and expressed as percentages with respect to pretreatment volumes. Heating did not significantly modify eGFP fluorescence intensity was measured using FACS 24 h from heat shock. Bonferroni's test for pairwise comparisons: *Po0.001 with respect to V1 and V2; **Po0.001 with respect to V1.
the growth pattern of PSN1 tumors. Untreated PSN1-DTA197 growth was similar to that in PSN1 tumors. Treated PSN1-DTA197 tumor growth was delayed with respect to that in untreated PSN1-DTA197 tumors, although the difference did not attain statistical significance, probably because of the small number of cases (repeated measures analysis of variance: F ¼ 5.89, P ¼ 0.07). Surprisingly, growth in PSN1-DTA197 tumors of unheated flanks of treated mice was less than that in untreated PSN1-DTA197, although not to a statistically significant extent (F ¼ 1.16, p:ns). The overlapping growth pattern of heated and unheated tumor masses in PSN1-DTA197 inoculated and treated mice was confirmed by measuring tumors using optical imaging (Figure 5b ). Figure 5c reports longitudinal imaging of heated and unheated tumor masses of a representative-treated mouse. Fluorescence intensity images were acquired immediately before and 3, 6 and 9 days after the first treatment; the second treatment was applied soon after the image was acquired at the 3rd day. DTA197 mRNA expression was quantified in six tumor masses: two were from an untreated mouse (control), two were from heated flanks and two were from unheated flanks of experimental mice. With respect to control masses, a 7.13-and 5.60-fold increase was found in the two heated masses and 3.03-and 2.99-fold increase was found in the two unheated masses.
Discussion
Hsp70B' belongs to the HSP70 family, which comprises at least eight unique gene products differing from each other in cellular localization, expression level and amino-acid sequence. 32, 33, 39 This protein is reported to be strictly inducible by cellular stress, although it has moderate levels of expression in dendritic cells, monocytes and natural killer blood cells. 33 The main aim of this study was to engineer a DNA vector with expression that could be controlled by heat, using the promoter sequence of HSPA6. As no data are present in the literature on Hsp70B' expression in PC cells known to express other Hsp70 proteins, 30, [34] [35] [36] we evaluated whether PC cell lines contain basal or heat-induced Hsp70B' and found that this protein, absent in control cells, was present in treated cells 24 h after heat shock. The HSPA6 promoter, therefore, seems to be a suitable heat responsive sequence for gene therapy applications in PC.
Exposure to high temperatures for long periods of time may be cytotoxic per se, 42 a welcome phenomenon if the target is a tumor cell, but potentially unfavorable in vivo, as hyperthermia can also damage non-neoplastic cells adjacent to the targeted tumor mass. 38, 43 With possible future in vivo applications in mind, we performed a series of experiments aiming to optimize both temperature and exposure time with a view to reach maximal levels of DTA gene therapy P Fogar et al expression of the transgene with minimal thermal shock. V1 transfected cell lines were maintained at 37 1C (control cells) or exposed to a 1 1C stepwise increase to reach a maximum temperature of 44 1C. An increase in reporter gene expression took place at a temperature of 39-43 1C, peaking at 42.5 1C. This temperature was thus chosen to identify the optimal exposure time interval: the minimum exposure time required for reaching the maximal transgene expression was 1.5 h. All subsequent heat shock experiments were, therefore, performed at 42.5 1C for 1.5 h. In the tested cell lines, heat shock induced a 4-10-fold increase in V1 transgene expression. To enhance heat responsiveness, we engineered two new promoters: one was an artificial nucleic acid sequence (104 bp) made up of five HSEs aligned in tandem head to head and tail to tail located upstream in the HSPA6 minimal promoter; the other was a construct consisting of the 104 bp sequence inserted downstream in the HSPA6 entire promoter. Two new eGFP expression vectors, V2 and V3, were obtained by replacing promoter V1 using the above-described DNA sequences. After heat shock, V2 protein-expression levels were equal to, or higher than, that of V1, but the best performance was observed in V3 transfected cells. The findings obtained at protein-expression analysis were confirmed in mRNA: a 20-30-fold increase was found in V3, and a median 10-fold increase in V1 or V2 transfected cell lines.
This first series of data show that (1) a DNA sequence including five HSEs allows post heat shock transcriptional levels comparable to those obtained with a complete HSP promoter, and has an advantage in that a smaller construct is easier to handle for gene therapy; (2) V3 has an advantage over V1 and V2 in that, after heat shock, it induces very high levels of expression of the protein under its control. However, all the vectors tested have a serious drawback: a minimal basal expression without there being any difference between vectors and cell type (Table 1, 37 1C) . DTA, a highly toxic molecule, may cause severe side effects, even at very low concentrations: one single molecule can kill a cell. 44 We, therefore, tested two variants of the toxin, as well as wild-type DTA; one (DTA176) was less toxic and the other (DTA197) was almost completely inactive.
18 V3 was chosen for controlling DTA and DTA variants transcription, as it is the most efficient of the three vectors after heat shock combined with low background transcription levels. As expected, the DTAwt vector caused significant cell growth impairment when transfected cells were maintained at 37 1C, there being some differences between cell lines. In fact, BxPC3 seemed to be less sensitive to the toxic effects of DTAwt than MIAPaCa2, PANC1 and PSN1. This difference was probably because of variations in transfection efficiency, which was about 30% in BxPC3 and about 80% in the other lines (data not shown). The cell cycle S phase had no impact on basal DTA toxicity: the higher percentage of cells in S phase was found among BxPC3 (38.5%), being o23% in all the other lines. Furthermore, similar to other toxins, DTA is known to act independently from the cell cycle phase. 45 Although estimated to be 10 to 20 times less toxic than DTA, 18, 46 the behavior of the DTA176 vector encoding the CRM176 variant was similar to that of DTAwt, thus further showing the power of this toxin. As expected, no significant basal toxicity was encountered among cells transfected with the DTA197 vector, which encodes CRM197 that share the immunological properties of DTA, without incurring its toxicity. 18 However, PSN1 showed a slight growth inhibition with the DTA197 transfectant. This finding was probably because of the fact that the DTA197 variant is not completely safe and the PSN1 cell line is probably more sensitive to its toxic effects. These two possibilities were confirmed by the subsequent experiments: when DTA197 transcription was heat induced, a complete (PSN1) or partial (all the other cell lines) growth inhibition occurred. This variant cannot, therefore, be considered as a completely safe product, as reported in some recent studies, 47, 48 and, in our view, its effects are probably dose related. Unlike this DTA variant, when induced by heat shock, DTAwt and DTA176 completely arrested the growth of all cell lines, thus confirming that they are extremely toxic, and highlighting their handling difficulties, especially for in vivo applications. The use of a DNA vector encoding DTA197 under the control of an efficient heat sensitive promoter may enable us to obtain several end points in vivo: (1) minimal undesired side effects because of the low basal transcription levels of a compound with a mild toxicity and (2) high levels of transcription in selected anatomic areas. This may enable us not only to directly kill tumor cells, but also, as recently described in patients with advanced stage solid tumors, to induce an antitumoral immune reaction. 49, 50 Preliminary in vivo experiments with the DTA197-expression vector and the most sensitive cell line in vitro, PSN1, were, therefore, performed. We first showed that nude mice tolerate two heat exposures (42 1C for 15 min), which induce a ninefold increase in eGFP transcription in tumors developed from V3 transfected PSN1 cells. When tumors were derived from DTA197 stably transfected PSN1 cells implants, heat treatment was followed by steadiness in volume, when this was measured by caliper. A more accurate evaluation of viable tumor cells, achieved with imaging techniques, showed that treatment caused a reduction in tumor masses, which almost completely disappeared in one treated mouse. Surprisingly, unheated tumor masses of treated mice were affected in a similar way as directly heated tumors, probably because the relatively small distance between heated and unheated flanks allowed warming of both. The long-term effects of the DTA197 vector were confirmed in vitro using limited dilution experiments with the same cell line.
In conclusion, DTA197 expression under the control of the heat-inducible promoter engineered by us seems to be a promising tool in arresting PC growth both in vitro and in vivo.
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